Taking Sales from $0 to $200K+ per Month

Summary

A new medical device brand, TempraMed, approached Surgely to kickstart sales and prove product-market fit for its new medical device for insulin pen protection. 

‍

After working with another agency, they were unable to drive profitable sales, and saw ROAS close to 0. Because the product was first of its kind, they had to determine if the problem was product-market fit, or the previous marketing efforts

‍

After 12 months of working with Surgely, TempraMed went from nearly $0 sale to reaching its first $200K month, while enjoying an above average conversion rate, and proving out product-market fit to its investors.

‍

We provided general growth strategy, paid media (Paid Social, Paid Search).

‍

What we've done

Strategic Discovery:

We started with comprehensive business, target audiences and competitive audits to develop an informed strategy.

‍

We identified opportunities around attribution/analytics, creative strategy, conversion rate, AOV, LTV, and more. This informed our 30/60/90 day plan. Once defined and aligned with the client, we executed. 

‍

Analytics / Attribution:

One of the biggest challenges for marketers after iOS14 has been accurate analytics/attribution for what ads are converting, and worse pixel performance due to limitations following privacy changes.

‍

Surgely quickly deployed a combination of 3rd party tracking solutions that enabled the brand to not only accurately see which campaigns/ads are converting sales, but also feed conversion data back to Meta/Google to increase retargeting pools, improve conversion tracking accuracy, and ultimately improve performance of the channel algorithmically (bringing the channel/pixel to perform how it used to).

‍

Conversion Rate Optimization: 

Surgely worked closely with the TempraMed development team to provide Conversion Rate Optimization strategy that unlocked DTC growth, starting at 0% and reaching above average in its industry. 

‍

From completely revamping PDPs to the introduction of listicles, videos, and other top of the funnel content - TempraMed’s conversion rates continue to see consistent growth.

‍

AOV:

While TempraMed’s product already has a high cost, increasing AOV is a low hanging fruit way to improve profitability. Surgely implemented post purchase upsell strategies that instantly increased AOV and ultimately revenue by 10-15%, from the same amount of sales and customers. 

‍

By introducing bundle offers and tiered discounts based on number of units purchased, AOV further increased by 40-50%.

‍

Creative Direct Response Strategy: 

As a new brand, TempraMed had a limited base of product, UGC and other content. Surgely worked in hand with TempraMed to vet and hire various design resources, and create a creative content pipeline.

‍

Next up, we wove all the components together, along with messaging that drove conversion, into a cohesive content strategy that drew attention, engaged, and drove sales. 

‍

Email / SMS / Lifecycle

Owned audiences are ultimately more powerful than purely paid audiences - and Email and SMS having an average ROAS of 20-40x is proof this channel must be prioritized in every D2C strategy. 

‍

Surgely started and scaled TempraMed’s email and lifecycle program, taking it from 0% of sales to 25-45% of monthly sales. 

‍

Scaling and Ongoing Optimization: after driving strong results from initial campaigns, we have been working with the brand for continued scaling of the account. 

‍

‍

Our results

After 12 months of working with Surgely, TempraMed went from nearly $0 sale to reaching its first $200K month, while enjoying an above average conversion rate, and proving out product-market fit to its investors.